NOC
45
5
HRL
30
3
EXC
56
2
SYF
92
7
NEE
49
5
VLO
30
2
SRCL
34
3
UAL
77
4
DAL
85
6
MPC
34
4
PLD
60
12
ACN
70
14
MOS
36
3
ECL
72
2
ED
39
2
HON
67
3
PFG
67
3
FDX
34
7
KEY
55
2
LMT
49
4
NOC
45
5
HRL
30
3
EXC
56
2
SYF
92
7
NEE
49
5
VLO
30
2
SRCL
34
3
UAL
77
4
DAL
85
6
MPC
34
4
PLD
60
12
ACN
70
14
MOS
36
3
ECL
72
2
ED
39
2
HON
67
3
PFG
67
3
FDX
34
7
KEY
55
2
LMT
49
4
Financhill
Back

ProShares UltraPro S&P500 Vs. Kymera Therapeutics Industry Stock Comparison

Buy
57

UPRO
ProShares UltraPro S&P500

Last Price:
89.91
Seasonality Move:
17.27%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
47.65
Seasonality Move:
65.72%
Buy
57
ProShares UltraPro S&P500 (UPRO) is a Buy

Is ProShares UltraPro S&P500 a Buy, Sell or Hold?

  • The current ProShares UltraPro S&P500 [UPRO] share price is $89.37. The Score for UPRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • UPRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UPRO Stock Price Chart

What is ProShares UltraPro S&P500's stock price today?

  • The ProShares UltraPro S&P500 share price today is $89.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

UPRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.27 Buy
Relative Strength Index (14 RSI): 62.59 Buy
Chaikin Money Flow: 1882700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.05 - 87.47) Buy
Bollinger Bands (100): (72.93 - 84.03) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

UPRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.39 Buy
20-day SMA: 85.78 Buy
50-day SMA: 80.75 Buy
200-day SMA: 71.02 Buy
8-day EMA: 87.76 Buy
20-day EMA: 85.55 Buy
50-day EMA: 82.08 Buy
200-day EMA: 71.34 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares UltraPro S&P500 Earnings Growth & UPRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares UltraPro S&P500 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):